Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer

Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.